Rock Springs Capital Management LP Homology Medicines, Inc. Transaction History

Rock Springs Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $3.5 Million - $5.83 Million	-351,638 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$12.07 - $19.34 $885,479 - $1.42 Million	-73,362 Reduced 17.26%	351,638 $5.34 Million
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $1.01 Million - $1.67 Million	55,000 Added 14.86%	425,000 $8.32 Million
Q1 2019 May 15, 2019	SELL	$19.76 - $29.57 $1.58 Million - $2.37 Million	-80,000 Reduced 17.78%	370,000 $10.3 Million
Q4 2018 Feb 14, 2019	SELL	$18.39 - $26.3 $367,800 - $526,000	-20,000 Reduced 4.26%	450,000 $10.1 Million
Q2 2018 Aug 14, 2018	SELL	$16.49 - $21.55 $1.73 Million - $2.26 Million	-105,000 Reduced 18.26%	470,000 $9.59 Million
Q1 2018 May 15, 2018	BUY	$18.66 - $18.7 $10.7 Million - $10.8 Million	575,000 New	575,000 $10.8 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.